TY  - JOUR
AU  - Barbarroja, Nuria
AU  - Arias-de la Rosa, Ivan
AU  - Lopez-Medina, Clementina
AU  - Camacho-Sanchez, Maria Del Rosario
AU  - Gomez-Garcia, Ignacio
AU  - Velez Garcia-Nieto, Antonio
AU  - Escudero-Contreras, Alejandro
AU  - Lopez-Pedrera, Chary
AU  - Lopez-Montilla, Maria Dolores
AU  - Collantes-Estevez, Eduardo
PY  - 2019
DO  - 10.1177/1759720X19880742
SN  - 1759-720X
UR  - http://hdl.handle.net/10668/15522
T2  - Therapeutic advances in musculoskeletal disease
AB  - Cardiovascular disease (CVD) is the main cause of mortality in patients with psoriatic disease. Traditional cardiovascular (CV) risk factors, such as arterial hypertension (HTA), type 2 diabetes (T2D), and dyslipidaemia are more prevalent in these...
LA  - en
PB  - Sage Publications
KW  - Arthritis, psoriatic
KW  - Cardiovascular diseases
KW  - Diabetes mellitus, type 2
KW  - Technology assessment, biomedical
KW  - Psoriasis
KW  - Risk factors
KW  - Hypertension
KW  - Inflammation
KW  - Atherosclerosis
KW  - Dyslipidemias
TI  - Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis.
TY  - research article
VL  - 11
ER  -